PDLI Stock-Based Compensation
Pdl Biopharma Inc · Stock-Based Compensation

PDLI Stock-Based Compensation
Latest reported$20.52Mperiod ending
PDLI TTM Stock-Based Comp ($0.00 → $20.52M)
TTM stock-based compensation
High-resolution chart · PNG
PDLI stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 20,518,000 | |
| 21,775,000 | |
| 23,719,000 | |
| 7,119,000 | |
| 5,347,000 | |
| 5,884,000 | |
| 4,970,000 | |
| 4,758,000 | |
| 4,938,000 | |
| 3,281,000 | |
| 2,983,000 | |
| 3,138,000 | |
| 4,107,000 | |
| 4,218,000 | |
| 4,068,000 | |
| 3,742,000 | |
| 3,346,000 | |
| 2,917,000 | |
| 2,330,000 | |
| 2,045,000 | |
| 1,823,000 | |
| 1,612,000 | |
| 1,808,000 | |
| 1,501,000 | |
| 1,339,000 | |
| 1,115,000 | |
| 910,000 | |
| 872,000 | |
| 821,000 | |
| 874,000 | |
| 889,000 | |
| 937,000 | |
| 806,000 | |
| 699,000 | |
| 541,000 | |
| 387,000 | |
| 393,000 | |
| 427,000 | |
| 524,000 | |
| 662,000 | |
| 729,000 | |
| 778,000 | |
| 813,000 | |
| 821,000 | |
| 617,000 | |
| 402,000 | |
| 196,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |